Laurie Kowalevsky

SVP Consumer Experience Hub, Lilly USA

Laurie Kowalevsky is a senior executive at Eli Lilly and Company, currently serving as the Senior Vice President of Consumer Experience Hub for Lilly USA.1 Her career at Eli Lilly spans over a decade, during which she has held several high-profile positions within the company.

Career Progression at Eli Lilly

Laurie's journey at Eli Lilly showcases a steady climb through various leadership roles:

SVP Strategy and Chief Marketing Officer, Lilly Immunology (October 2021 - Present)1
VP Global Marketing and Chief Marketing Officer, Lilly BioMedicines (July 2018 - October 2022)1
Global Brand Leader, Immunology (2013 - July 2018)1
Sr. Director, Immunology Customer Support Programs (March 2013 - November 2015)1
US Brand Leader, Men's Health (2010 - 2013)1
Brand Manager - Consumer Marketing - Men's Health (2007 - 2010)1

Notable Achievements

Laurie has made significant contributions to Eli Lilly beyond her primary roles:

Founding Chairwoman of Women's Initiative for Leading at Lilly (WILL) (2014 - April 2018): She led the transformation of Lilly's Women's Network, focusing on enhancing the experience of women at Lilly and addressing barriers to their advancement.1
Product Launches: She was responsible for launching new indications and formulations in the Men's Health division.1

Background and Education

Prior to joining Eli Lilly, Laurie worked as an EVP Client Services at Publicis from 2002 to 2007, where she led strategic development and managed client relationships.1

Laurie holds a Bachelor's degree in Broadcast Journalism/Business from Indiana University Bloomington.1

Personal Interests

Outside of her professional life, Laurie describes herself as a passionate individual who cares deeply about the things that matter to her. She identifies as a proud mom, wife, brand builder, strategic thinker, and gender advocate.2

Laurie Kowalevsky's career trajectory demonstrates her expertise in marketing, strategy, and leadership within the pharmaceutical industry, particularly at Eli Lilly and Company.